EarningsQ1 2022 Earnings Report

Nektar Therapeutics (NKTR) Q1 2022 Earnings Report

0 Followers

MX:NKTR Q1 2022 EPS Results

Actual EPS-$135.17

Consensus EPS-$174.05

Beat/MissBeat by +$38.88

One Year Ago EPS-$187.59

Actual Revenue$456.50M

Expected Revenue$446.85M

Beat/MissBeat by +$9.66M

YoY Revenue Growth+4.97%

QuarterQ1 2022

Date05/05/2022

TimeAfter Close

Conference CallThursday, May 5, 2022

MX:NKTR Upcoming Earnings

Nektar Therapeutics's next earnings date is estimated for November 5, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 05, 2026	2026 (Q3)	-37.94 / -	-34.391	―
Aug 13, 2026	2026 (Q2)	-36.25 / -22.62	-54.254	58.31% (+31.63)
May 07, 2026	2026 (Q1)	-29.09 / -33.47	-66.208	49.44% (+32.74)
Mar 12, 2026	2025 (Q4)	-45.50 / -32.74	8.276	-495.56% (-41.01)
Nov 06, 2025	2025 (Q3)	-49.38 / -34.39	-49.656	30.74% (+15.26)
Aug 07, 2025	2025 (Q2)	-55.69 / -54.25	-68.967	21.33% (+14.71)
May 08, 2025	2025 (Q1)	-47.15 / -66.21	-52.415	-26.32% (-13.79)
Mar 12, 2025	2024 (Q4)	-37.41 / 8.28	-60.691	113.64% (+68.97)
Nov 07, 2024	2024 (Q3)	-54.90 / -49.66	-66.208	25.00% (+16.55)
Aug 08, 2024	2024 (Q2)	-51.04 / -68.97	-74.484	7.41% (+5.52)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed